Inappropriate therapy of postoperative pain in laparoscopic cholecystectomy may lead to late mobilization, patient dissatisfaction, delayed hospital discharge, and chronic pain development. Our objective was to identify the best therapeutic strategy available to the anesthesiologist for the acute postoperative pain of patients submitted to elective laparoscopic cholecystectomy. This is a systematic review that included 36 complete articles indexed in the Medline, Scopus, Web of Science and LILACS databases, with a five-year time cut (2012 to 2016), resulting from controlled and randomized studies that were submitted to qualitative analysis. In a proposal for multimodal analgesia, it is important to consider the contraindications, adverse effects, dose and optimal timing of interventions. Non-opioid drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs)/cyclooxygenase-2 (COX-2) inhibitors, gabapentin/pregabalin, N-methyl-D-aspartate (NMDA) receptor antagonists, and others. Opioids may be used at low doses associated with multimodal therapy or are restricted to cases where non-opioid multimodal analgesia is insufficient. We conclude that there is no consensus as to the best analgesic strategy to be implemented in the acute postoperative pain of laparoscopic cholecystectomy, which requires its applicability in an individualized way, based on the scientific evidence found in the literature. As contribution to medical learning and practice, we point out the theoretical enrichment of the analgesic drug options available for the therapy of postoperative pain in patients submitted to elective laparoscopic cholecystectomy, and alert the team to consider the adverse effects of the interventions implemented.
INTRODUCTION
T he inadequate treatment of postoperative pain in laparoscopic cholecystectomy (LC) can lead to negative consequences, such as late mobilization, with consequent delay in discharge, development of chronic pain and increased treatment costs 1 .
In recent years, multimodal analgesia has been recommended to combine additive and synergistic effects of different analgesics, with less adverse effects and more effective analgesia [1] [2] [3] . Systematic 4 . The other study recommended a single preoperative dose of dexamethasone, local anesthetics in the incisions (at the beginning or at the end of the surgery, depending on the anesthesiologist's preference), and continued treatment with non-steroidal antiinflammatory drugs (NSAIDs)/COX-2 during the first three to four days, reserving the opioids for when other analgesic techniques fail 5 .
The objective was to identify the best therapeutic strategy available to the anesthesiologist for treatment of acute postoperative pain of patients submitted to elective laparoscopic cholecystectomy.
METHODS
reviewer, following the steps for the design of a systematic review 6 . For the search of the scientific productions, we used the following combination of "Descritores em Ciências da Saúde" (DeCS) and
Medical Subject Headings (MeSH) terms, in English, Portuguese and Spanish: "postoperative pain" ("dor pós-operatória", "dolor postoperatorio") AND There were 846 articles, of which 173 were duplicates, remaining 673 in the first selection. We then read the title and Abstract, prioritizing the sensitivity in detriment of the specificity in order to make a selection of these references 6 . This was done by a pair of reviewers, independently. The article was considered when at least one of the reviewers judged it as eligible. This process resulted in 145 articles that could be submitted to a complete reading. If there was disagreement between the reviewers, these were resolved either by consensus between the reviewers or by consulting a third reviewer.
There were 109 rejected articles and 36 were accepted to compose the definitive set ( Figure 1 ). All articles that met the eligibility criteria for the systematic review had their methodological quality evaluated individually, minimizing biases and maximizing internal and external validity 6 . To that end, we assessed adequate randomization (allocation sequence generation), guaranteed allocation, blinding scheme (participants, team involved in conducting the study, outcome assessors), intention-to-treat analysis, loss of followup, as well as other sources of bias, such as early termination of the study due to benefit. We organized the articles 1-3,7-38 included in this systematic review and described in table 1. Through the convergence of the findings that answered the question of the study, we grouped the evidence according to the available therapeutic strategies for the control of acute pain after elective LC with the necessary comments to the discussion.
RESULTS AND DISCUSSION
In total, we identified 36 controlled and randomized clinical trials, including 2526 patients (Table 1) .
NSAIDs/COX-2 inhibitors
Many studies have been done evaluating the risk-benefit of several NSAIDs/COX-2 inhibitors.
The majority of the studies reviewed showed a reduction in the acute pain scores and the need for opioids in the postoperative period of LC, with adverse effects not found and/or not analyzed.
There is no substantial superiority between the NSAIDs/COX-2 inhibitors available, and it is up to the anesthesiologist to decide which medication to use, according to the options available. However, their use is recommended as a key element within a There was no difference in postoperative adverse effects and opioid consumption 16 .
The use of flupirtine 200mg VO two hours before surgery was superior to placebo for acute postoperative pain, but there was no difference in opioid consumption. Nonetheless, there was a higher incidence of sedation in the group studied 15 .
Gabapentin/Pregabalin
In general, the use of gabapentin/ pregabalin in patients undergoing LC also showed lower scores of acute pain and need for opioid in the postoperative period, but several studies have shown adverse effects that may limit their use, such as sedation, delayed extubation and dizziness.
Administration of pregabalin 150mg or 300 mg VO an hour before surgery decreased pain intensity and opioid consumption after LC compared with placebo. There was a higher degree of sedation on the Ramsay scale in the 300mg pregabalin group 25 .
This dose, on the night before surgery and one hour before surgery, when compared with placebo, also obtained these positive analgesic results, albeit associated with delayed extubation time, as well as with increased incidence of post-operative dizziness 24 .
The isolated use of pregabalin 150mg VO or in combination with celecoxib 400mg one hour before surgery did not provide lower pain scores or need for opioid when compared with placebo.
The pregabalin group presented more dizziness and somnolence 22 . The use of gabapentin 1200mg VO two hours before surgery, followed by the same dose 12 hours postoperatively and every eight hours for two days, and pregabalin 150mg VO in the same administration scheme, reduced the need for opioids in patients undergoing LC when compared with placebo. The pregabalin group showed lower pain scores when compared with the other groups.
Non-placebo interventions resulted in a greater
degree of dizziness and drowsiness 23 .
Miscellaneous
Interventions that could not be amassed in the previous groups were considered miscellaneous. LC had reduced pain scores when coughing, but not at rest, when compared with those who did not receive the block. Postoperative opioid consumption was lower 36 . Another similar study showed reduction of postoperative acute pain, but the reduction in the need for opioids in the postoperative period was not evaluated 32 .
An oblique subcostal approach in the use of a single-injection TAP block was effective in the control of LC postoperative pain and decreased opioid consumption 33 . This block showed lower postoperative pain and opioid need scores in comparison to the posterior TAP block or no blockade 35 . When two groups undergoing epidural block were compared in a LC surgery, the associated use of clonidine with levobupivacaine resulted in less analgesic need in the treatment of shoulder pain compared with clonidine with ropivacaine, but both groups had a high decline in blood pressure, requiring vasopressors 34 .
Opioids
Opioids are the best option for analgesia.
However, due to their potential for chemical dependence and adverse effects, several other drugs appear on the market every day. Currently, the combination of drugs is recommended to approximate the analgesic quality of opioids, a therapy known as multimodal. Researches involving opioids aim for greater efficacy with the fewest possible adverse effects. In this sense, the use of oxycodone has been shown to be promising in patients submitted to LC 37 .
Oxycodone 0.08mg/kg IV 20 minutes before the end of surgery relieved immediate postoperative pain when compared with fentanyl 1mcg/kg, and was not associated with an increase in side effects in patients submitted to LC. The need for additional doses was similar between groups 37 .
Regarding its use by patient-controlled analgesia, oxycodone 1mg IV per bolus showed similar effects for pain relief compared with fentanyl 10mcg IV, but showed a higher incidence of postoperative nausea and vomiting 38 .
Despite the viability of the various strategies for acute pain relief in patients undergoing LC, some studies have not investigated the adverse effects of interventions, only efficacy in postoperative analgesia and the need for opioids. This can be explained by the rarity of their occurrences, difficulty in evaluation, or because they were not the objective of these studies 4 .
The heterogeneity of the review studies may have led to weaknesses in the discussion. Nevertheless, this systematic review of the literature has contributed to teaching and professional practice with the theoretical enrichment of the analgesic tools available for LC therapy, as well as to alert the team to consider the adverse effects of the implemented interventions. Our study did not consider surgical strategies in the treatment of acute pain relief of patients undergoing LC, but these should be valued in the search for a better analgesic strategy.
CONCLUSION
There is no consensus as to the best analgesic strategy to be implemented in the acute postoperative pain of laparoscopic cholecystectomy, which requires its applicability in an individualized way, based on the scientific evidence found in the literature. A terapêutica inadequada da dor pós-operatória em colecistectomia videolaparoscópica pode levar a mobilização tardia, insatisfação do paciente, atraso na alta hospitalar e desenvolvimento de dor crônica. Objetivou-se identificar qual a melhor estratégia terapêutica disponível ao anestesiologista na terapia da dor aguda pós-operatória de pacientes submetidos à colecistectomia videolaparoscópica eletiva. Trata-se de revisão sistemática que incluiu 36 artigos completos indexados nas bases de dados Medline, Scopus, Web of Science e LILACS, com recorte temporal de cinco anos (2012 a 2016), resultantes de estudos controlados e randomizados que foram submetidos à análise qualitativa. Em uma proposta de analgesia multimodal, é importante considerar as contraindicações, os efeitos adversos, a dose e o momento ideal das intervenções. Utiliza-se fármacos não opioides, como anti-inflamatórios não esteroides (AINES)/inibidores da ciclo-oxigenase-2 (COX-2), gabapentina/pregabalina, antagonistas dos receptores N-methyl-D-aspartato (NMDA), entre outras. Os opioides podem ser utilizados em doses baixas associadas ou não a terapia multimodal e/ou ficarem restritos aos casos em que a analgesia multimodal não opioide for insuficiente. Conclui-se que não há consenso sobre qual a melhor estratégia analgésica a ser implementada na dor aguda pós-operatória da colecistectomia videolaparoscópica, o que requer sua aplicabilidade de forma individualizada, com base nas evidências científicas encontradas na literatura. Aponta-se como contribuições para o ensino e a prática profissional o enriquecimento teórico das opções medicamentosas analgésicas disponíveis para a terapêutica da dor pós-operatória de pacientes submetidos à colecistectomia videolaparoscópica eletiva, além de alertar a equipe para considerar os efeitos adversos das intervenções implementadas.
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